Synergy Immunotherapeutics (IMT) is committed to serving those in need by creating highly efficacious therapeutics to treat cancer and neurodegenerative diseases.   To enhance therapeutic activity, Synergy IMT creates innovative multifunctional immunotherapeutics and antibody drug-conjugates to kill tumor cells and induce or revitalize an anti-tumor immune response.  Multifunctional agonists of certain targets are developed to treat neurodegenerative and other diseases.